Risk of Ocular Hypertension With Intravitreal Triamcinolone Compared to the Dexamethasone Implant.

J Vitreoretin Dis · 2026 · PMC13216112 · PMID 42221737

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significanceP = .18not close (p > 0.1)

Cox proportional hazards regression analysis showed that the risk of progression to a diagnosis of suspected glaucoma or glaucoma after 40 days postinjection was similar in the dexamethasone implant group compared with the IVT triamcinolone group, but this did not reach statistical significance (HR, 1.24, 95% CI, 0.91–1.70; P = .18).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.